English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Multidrug resistant uropathogens have complicated the treatment of community acquired urinary tract infections.[1] With emerging resistance among all classes of antibiotics, very few of them demonstrate high levels of susceptibility among uropathogens.[2] Fosfomycin has emerged as an effective oral option for treating urinary tract infections. We conducted an in vitro study to assess the susceptibility profile of sensitive and multidrug resistant pathogens against fosfomycin at our centre.

Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens